Optinose to Present at BMO Capital Markets Prescription for Success Healthcare Conference

[End Subhead]
[Start Distributor]
GlobeNewswire 7-Dec-2017 4:05 PM
[End Distributor]
YARDLEY, Pa., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive Officer Peter Miller will present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare ConferenceDecember 14, 2017, at 9 am ET in New York. To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website. A replay of the webcast will be available for 90 days following the conclusion of the event.
About Optinose
Optinose is a specialty pharmaceutical company on a mission to improve lives with a focus on patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has corporate offices in the U.S., the U.K. and Norway. To learn more, please visit www.optinose.com.
Optinose Media Contact Kate Traynor, Sloane & CompanyKtraynor@sloanepr.com212.446.1871
Optinose Investor Contact Jonathan Neely Jonathan.neely@optinose.com 973.722.4356

Wait, Before You Leave...